XML 31 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantor Non-Guarantor Subsidiary Financial Information Level 3 (Tables)
6 Months Ended
Jun. 30, 2012
Guarantor - Condensed Consolidating Statements of Operations [Abstract]  
Condensed Consolidating Statement of Operations [Table Text Block]
MOMENTIVE SPECIALTY CHEMICALS INC.
THREE MONTHS ENDED JUNE 30, 2012
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
576

 
$
—

 
$
—

 
$
761

 
$
(78
)
 
$
1,259

Cost of sales
484

 
—

 
—

 
681

 
(78
)
 
1,087

Gross profit
92

 
—

 
—

 
80

 
—

 
172

Selling, general and administrative expense
17

 
—

 
—

 
62

 
—

 
79

Business realignment costs
2

 
—

 
—

 
1

 
—

 
3

Other operating (income) expense, net
(4
)
 
—

 
—

 
2

 
—

 
(2
)
Operating income
77

 
—

 
—

 
15

 
—

 
92

Interest expense, net
14

 
46

 
—

 
7

 
—

 
67

Intercompany interest expense (income)
35

 
(49
)
 
—

 
14

 
—

 
—

Other non-operating expense (income), net
22

 
—

 
1

 
(24
)
 
—

 
(1
)
Income (loss) from continuing operations before income tax, earnings from unconsolidated entities
6

 
3

 
(1
)
 
18

 
—

 
26

Income tax expense
3

 
—

 
—

 
1

 
—

 
4

Income (loss) from continuing operations before earnings from unconsolidated entities
3

 
3

 
(1
)
 
17

 
—

 
22

Earnings from unconsolidated entities, net of taxes
25

 
—

 
5

 
2

 
(26
)
 
6

Net income
$
28

 
$
3

 
$
4

 
$
19

 
$
(26
)
 
$
28

Comprehensive (loss) income
$
(15
)
 
$
—

 
$
5

 
$
(2
)
 
$
(3
)
 
$
(15
)
MOMENTIVE SPECIALTY CHEMICALS INC.
THREE MONTHS ENDED JUNE 30, 2011
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
617

 
$
—

 
$
—

 
$
912

 
$
(91
)
 
$
1,438

Cost of sales
488

 
—

 
—

 
826

 
(91
)
 
1,223

Gross profit
129

 
—

 
—

 
86

 
—

 
215

Selling, general and administrative expense
34

 
—

 
—

 
53

 
—

 
87

Asset impairments
—

 
—

 
—

 
18

 
—

 
18

Business realignment costs
—

 
—

 
—

 
5

 
—

 
5

Other operating income, net
(4
)
 
—

 
—

 
(19
)
 
—

 
(23
)
Operating income
99

 
—

 
—

 
29

 
—

 
128

Interest expense, net
17

 
38

 
—

 
10

 
—

 
65

Intercompany interest expense (income)
35

 
(48
)
 
—

 
13

 
—

 
—

Other non-operating (income) expense, net
(9
)
 
—

 
—

 
9

 
—

 
—

Income (loss) from continuing operations before income tax, earnings from unconsolidated entities
56

 
10

 
—

 
(3
)
 
—

 
63

Income tax (benefit) expense
(11
)
 
1

 
—

 
10

 
—

 
—

Income (loss) from continuing operations before earnings from unconsolidated entities
67

 
9

 
—

 
(13
)
 
—

 
63

(Losses) earnings from unconsolidated entities, net of taxes
(3
)
 
—

 
(3
)
 
—

 
9

 
3

Net income (loss) from continuing operations
64

 
9

 
(3
)
 
(13
)
 
9

 
66

Net loss from discontinued operations, net of tax
(1
)
 
—

 
—

 
(2
)
 
—

 
(3
)
Net income (loss)
$
63

 
$
9

 
$
(3
)
 
$
(15
)
 
$
9

 
$
63

Comprehensive income (loss)
$
84

 
$
10

 
$
(3
)
 
$
2

 
$
(9
)
 
$
84

 
MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2012
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
1,114

 
$
—

 
$
—

 
$
1,530

 
$
(149
)
 
$
2,495

Cost of sales
938

 
—

 
—

 
1,356

 
(149
)
 
2,145

Gross profit
176

 
—

 
—

 
174

 
—

 
350

Selling, general and administrative expense
47

 
—

 
—

 
117

 
—

 
164

Asset impairments
—

 
—

 
—

 
23

 
—

 
23

Business realignment costs
4

 
—

 
—

 
14

 
—

 
18

Other operating expense, net
1

 
—

 
—

 
8

 
—

 
9

Operating income
124

 
—

 
—

 
12

 
—

 
136

Interest expense, net
30

 
85

 
—

 
17

 
—

 
132

Intercompany interest expense (income)
65

 
(91
)
 
—

 
26

 
—

 
—

Other non-operating expense (income), net
11

 
—

 
—

 
(10
)
 
—

 
1

Income (loss) from continuing operations before income tax, earnings from unconsolidated entities
18

 
6

 
—

 
(21
)
 
—

 
3

Income tax expense
2

 
—

 
—

 
—

 
—

 
2

Income (loss) from continuing operations before earnings from unconsolidated entities
16

 
6

 
—

 
(21
)
 
—

 
1

(Losses) earnings from unconsolidated entities, net of taxes
(4
)
 
—

 
3

 
2

 
10

 
11

Net income (loss)
$
12

 
$
6

 
$
3

 
$
(19
)
 
$
10

 
$
12

Comprehensive (loss) income
$
(2
)
 
$
4

 
$
4

 
$
(23
)
 
$
15

 
$
(2
)
MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2011
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
1,180

 
$
—

 
$
—

 
$
1,725

 
$
(173
)
 
$
2,732

Cost of sales
955

 
—

 
—

 
1,526

 
(173
)
 
2,308

Gross profit
225

 
—

 
—

 
199

 
—

 
424

Selling, general and administrative expense
64

 
—

 
—

 
107

 
—

 
171

Asset impairments
—

 
—

 
—

 
18

 
—

 
18

Business realignment costs
2

 
—

 
—

 
6

 
—

 
8

Other operating income, net
(21
)
 
—

 
—

 
—

 
—

 
(21
)
Operating income
180

 
—

 
—

 
68

 
—

 
248

Interest expense, net
35

 
75

 
—

 
19

 
—

 
129

Intercompany interest expense (income)
64

 
(90
)
 
—

 
26

 
—

 
—

Other non-operating (income) expense , net
(36
)
 
—

 
(1
)
 
35

 
—

 
(2
)
Income (loss) from continuing operations before income tax, earnings from unconsolidated entities
117

 
15

 
1

 
(12
)
 
—

 
121

Income tax (benefit) expense
(19
)
 
2

 
—

 
20

 
—

 
3

Income (loss) from continuing operations before earnings from unconsolidated entities
136

 
13

 
1

 
(32
)
 
—

 
118

Earnings from unconsolidated entities, net of taxes
8

 
—

 
15

 
—

 
(17
)
 
6

Net income (loss) from continuing operations
144

 
13

 
16

 
(32
)
 
(17
)
 
124

Net (loss) income from discontinued operations, net of tax
(18
)
 
—

 
—

 
20

 
—

 
2

Net income (loss)
$
126

 
$
13

 
$
16

 
$
(12
)
 
$
(17
)
 
$
126

Comprehensive income
$
177

 
$
18

 
$
16

 
$
3

 
$
(37
)
 
$
177

Condensed Consolidating Balance Sheet [Table Text Block]
MOMENTIVE SPECIALTY CHEMICALS INC.
JUNE 30, 2012
CONDENSED CONSOLIDATING BALANCE SHEET (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents (including restricted cash of $0 and $3, respectively)
$
255

 
$
—

 
$
—

 
$
81

 
$
—

 
$
336

Short-term investments
—

 
—

 
—

 
5

 
—

 
5

Accounts receivable, net
207

 
—

 
—

 
488

 
—

 
695

Inventories:
 
 
 
 
 
 
 
 
 
 
 
Finished and in-process goods
124

 
—

 
—

 
186

 
—

 
310

Raw materials and supplies
44

 
—

 
—

 
82

 
—

 
126

Other current assets
19

 
—

 
—

 
50

 
—

 
69

Total current assets
649

 
—

 
—

 
892

 
—

 
1,541

Other assets, net
85

 
45

 
29

 
98

 
(89
)
 
168

Property and equipment, net
494

 
—

 
—

 
653

 
—

 
1,147

Goodwill
93

 
—

 
—

 
73

 
—

 
166

Other intangible assets, net
56

 
—

 
—

 
40

 
—

 
96

Total assets
$
1,377

 
$
45

 
$
29

 
$
1,756

 
$
(89
)
 
$
3,118

Liabilities and (Deficit) Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
 
 
Accounts and drafts payable
$
173

 
$
—

 
$
—

 
$
317

 
$
—

 
$
490

Intercompany accounts payable (receivable)
28

 
(51
)
 
1

 
22

 
—

 
—

Debt payable within one year
11

 
—

 
—

 
54

 
—

 
65

Intercompany loans (receivable) payable
(118
)
 
—

 
—

 
118

 
—

 
—

Affiliated debt payable within one year
2

 
—

 
—

 
—

 
—

 
2

Interest payable
12

 
53

 
—

 
1

 
—

 
66

Income taxes (receivable) payable
(7
)
 
—

 
—

 
15

 
—

 
8

Accrued payroll and incentive compensation
9

 
—

 
—

 
29

 
—

 
38

Other current liabilities
75

 
—

 
—

 
62

 
—

 
137

Total current liabilities
185

 
2

 
1

 
618

 
—

 
806

Long-term debt
868

 
2,137

 
—

 
425

 
—

 
3,430

Intercompany loans payable (receivable)
1,650

 
(2,341
)
 
(19
)
 
710

 
—

 
—

Long-term pension and post employment benefit obligations
90

 
—

 
—

 
122

 
—

 
212

Deferred income taxes
15

 
2

 
—

 
43

 
—

 
60

Other long-term liabilities
112

 
6

 
—

 
34

 
—

 
152

Advance from affiliates
225

 
—

 
—

 
—

 
—

 
225

Total liabilities
3,145

 
(194
)
 
(18
)
 
1,952

 
—

 
4,885

Total Momentive Specialty Chemicals Inc. shareholders (deficit) equity
(1,768
)
 
239

 
47

 
(197
)
 
(89
)
 
(1,768
)
Noncontrolling interest
—

 
—

 
—

 
1

 
—

 
1

Total (deficit) equity
(1,768
)
 
239

 
47

 
(196
)
 
(89
)
 
(1,767
)
Total liabilities and (deficit) equity
$
1,377

 
$
45

 
$
29

 
$
1,756

 
$
(89
)
 
$
3,118



MOMENTIVE SPECIALTY CHEMICALS INC.
DECEMBER 31, 2011
CONDENSED CONSOLIDATING BALANCE SHEET
  
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents (including restricted cash of $0 and $3, respectively)
$
221

 
$
—

 
$
—

 
$
210

 
$
—

 
$
431

Short-term investments
—

 
—

 
—

 
7

 
—

 
7

Accounts receivable, net
206

 
—

 
—

 
386

 
—

 
592

Inventories:
 
 
 
 
 
 
 
 
 
 
 
Finished and in-process goods
116

 
—

 
—

 
138

 
—

 
254

Raw materials and supplies
33

 
—

 
—

 
70

 
—

 
103

Other current assets
27

 
—

 
—

 
45

 
—

 
72

Total current assets
603

 
—

 
—

 
856

 
—

 
1,459

Other assets, net
107

 
36

 
40

 
89

 
(103
)
 
169

Property and equipment, net
504

 
—

 
—

 
705

 
—

 
1,209

Goodwill
93

 
—

 
—

 
74

 
—

 
167

Other intangible assets, net
59

 
—

 
—

 
45

 
—

 
104

Total assets
$
1,366

 
$
36

 
$
40

 
$
1,769

 
$
(103
)
 
$
3,108

Liabilities and (Deficit) Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
 
 
Accounts and drafts payable
$
134

 
$
—

 
$
—

 
$
259

 
$
—

 
$
393

Intercompany accounts (receivable) payable
(24
)
 
(42
)
 
1

 
65

 
—

 
—

Debt payable within one year
17

 
—

 
—

 
100

 
—

 
117

Intercompany loans payable (receivable)
35

 
—

 
—

 
(35
)
 
—

 
—

Affiliated debt payable within one year
2

 
—

 
—

 
—

 
—

 
2

Interest payable
14

 
44

 
—

 
3

 
—

 
61

Income taxes payable
1

 
—

 
—

 
14

 
—

 
15

Accrued payroll and incentive compensation
26

 
—

 
—

 
31

 
—

 
57

Other current liabilities
69

 
—

 
—

 
63

 
—

 
132

Total current liabilities
274

 
2

 
1

 
500

 
—

 
777

Long-term debt
1,134

 
1,688

 
—

 
598

 
—

 
3,420

Intercompany loans payable (receivable)
1,254

 
(1,903
)
 
(16
)
 
665

 
—

 
—

Long-term pension and post employment benefit obligations
99

 
—

 
—

 
124

 
—

 
223

Deferred income taxes
30

 
2

 
—

 
40

 
—

 
72

Other long-term liabilities
116

 
6

 
—

 
34

 
—

 
156

Advance from affiliates
225

 
—

 
—

 
—

 
—

 
225

Total liabilities
3,132

 
(205
)
 
(15
)
 
1,961

 
—

 
4,873

Total Momentive Specialty Chemicals Inc. shareholders (deficit) equity
(1,766
)
 
241

 
55

 
(193
)
 
(103
)
 
(1,766
)
Noncontrolling interest
—

 
—

 
—

 
1

 
—

 
1

Total (deficit) equity
(1,766
)
 
241

 
55

 
(192
)
 
(103
)
 
(1,765
)
Total liabilities and (deficit) equity
$
1,366

 
$
36

 
$
40

 
$
1,769

 
$
(103
)
 
$
3,108

Condensed Consolidating Statement of Cash Flows [Table Text Block]
MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2012
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Cash flows provided by (used in) operating activities
$
13

 
$
8

 
$
12

 
$
(26
)
 
$
(18
)
 
$
(11
)
Cash flows provided by (used in) investing activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(25
)
 
—

 
—

 
(33
)
 
—

 
(58
)
Proceeds from matured debt securities, net
—

 
—

 
—

 
2

 
—

 
2

Funds remitted to unconsolidated affiliates
—

 
—

 
—

 
(3
)
 
—

 
(3
)
Capital contribution to subsidiary
(15
)
 
—

 
(10
)
 
—

 
25

 
—

Proceeds from the return of capital from subsidiary
42

 
—

 
—

 
—

 
(42
)
 
—

Proceeds from sale of assets
9

 
—

 
—

 
—

 
—

 
9

 
11

 
—

 
(10
)
 
(34
)
 
(17
)
 
(50
)
Cash flows provided by (used in) financing activities
 
 
 
 
 
 
 
 
 
 
 
Net short-term debt repayments
—

 
—

 
—

 
(15
)
 
—

 
(15
)
Borrowings of long-term debt
—

 
450

 
—

 
1

 
—

 
451

Repayments of long-term debt
(272
)
 
—

 
—

 
(201
)
 
—

 
(473
)
Net intercompany loan borrowings (repayments)
270

 
(439
)
 
(2
)
 
171

 
—

 
—

Capital contribution from parent
16

 
—

 
10

 
15

 
(25
)
 
16

Long-term debt and credit facility financing fees
(2
)
 
(11
)
 
—

 
—

 
—

 
(13
)
Common stock dividends paid
(2
)
 
(8
)
 
(10
)
 
—

 
18

 
(2
)
Return of capital to parent
—

 
—

 
—

 
(42
)
 
42

 
—

 
10

 
(8
)
 
(2
)
 
(71
)
 
35

 
(36
)
Effect of exchange rates on cash and cash equivalents
—

 
—

 
—

 
2

 
—

 
2

Increase (decrease) in cash and cash equivalents
34

 
—

 
—

 
(129
)
 
—

 
(95
)
Cash and cash equivalents (unrestricted) at beginning of period
221

 
—

 
—

 
207

 
—

 
428

Cash and cash equivalents (unrestricted) at end of period
$
255

 
$
—

 
$
—

 
$
78

 
$
—

 
$
333




MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2011
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Cash flows (used in) provided by operating activities
$
(46
)
 
$
—

 
$
6

 
$
53

 
$
(56
)
 
$
(43
)
Cash flows provided by (used in) investing activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(46
)
 
—

 
—

 
(25
)
 
—

 
(71
)
Change in restricted cash
—

 
—

 
—

 
2

 
—

 
2

Funds remitted to unconsolidated affiliates, net of dividend
5

 
—

 
(1
)
 
(5
)
 
—

 
(1
)
Proceeds from sale of business, net of cash transferred
173

 
—

 
—

 
—

 
—

 
173

Proceeds from the return of capital from subsidiary
33

 
—

 
—

 
—

 
(33
)
 
—

 
165

 
—

 
(1
)
 
(28
)
 
(33
)
 
103

Cash flows used in financing activities
 
 
 
 
 
 
 
 
 
 
 
Net short-term debt repayments
(8
)
 
—

 
—

 
—

 
—

 
(8
)
Borrowings of long-term debt
144

 
—

 
—

 
265

 
—

 
409

Repayments of long-term debt
(153
)
 
—

 
—

 
(298
)
 
—

 
(451
)
Return of capital to parent
—

 
—

 
—

 
(33
)
 
33

 
—

Common stock dividends paid
—

 
(4
)
 
(5
)
 
(47
)
 
56

 
—

Net intercompany loan (repayments) borrowings
(93
)
 
4

 
—

 
89

 
—

 
—

Long-term debt and credit facility financing fees
(1
)
 
—

 
—

 
—

 
—

 
(1
)
 
(111
)
 
—

 
(5
)
 
(24
)
 
89

 
(51
)
Effect of exchange rates on cash and cash equivalents
—

 
—

 
—

 
3

 
—

 
3

Increase in cash and cash equivalents
8

 
—

 
—

 
4

 
—

 
12

Cash and cash equivalents (unrestricted) at beginning of period
56

 
—

 
—

 
124

 
—

 
180

Cash and cash equivalents (unrestricted) at end of period
$
64

 
$
—

 
$
—

 
$
128

 
$
—

 
$
192